Drug recall · August 26, 2026
Carbamazepine Tablets recall
Why: CGMP deviations: tablets with black specks.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
- Lots / codes
Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028
- Quantity
- 1200 bottles
- Company
- Golden State Medical Supply Inc., Camarillo, CA
- Distribution
- USA Nationwide
- Initiated
- August 7, 2026 · Voluntary: Firm initiated
- Classified
- August 19, 2026
- Reported
- August 26, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Carbamazepine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.